Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Disorders of the Male Reproductive System

Disorders of the Male Reproductive System

Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Application of the research electronic data capture (REDCap) system in a low- and middle income country- experiences, lessons, and challenges.

Health and technology·2022

Same author

Radiation and hormonal therapy for primary treatment of stage I endometrial cancer and long-term survival.

Gynecologic oncology·2020

Same author

Contemporary management of men with high-risk localized prostate cancer in the United States.

Prostate cancer and prostatic diseases·2017

Same author

Contemporary management of men with high-risk localized prostate cancer in the United States.

Prostate cancer and prostatic diseases·2017

Same author

Mildly elevated serum alpha-fetoprotein (AFP) among patients with testicular cancer may not be associated with residual cancer or need for treatment.

Annals of oncology : official journal of the European Society for Medical Oncology·2017

Same author

The dimensions and symmetry of the seminal vesicles.

Journal of robotic surgery·2016

Search research articles

Related Experiment Video

Updated: May 27, 2026

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Published on: May 19, 2022

Cause-specific mortality following radical prostatectomy.

S Shikanov¹, M Kocherginsky, A L Shalhav

¹Section of Urology, Department of Surgery, University of Chicago, Chicago, IL, USA.

Prostate Cancer and Prostatic Diseases

|November 16, 2011

Summary

Radical prostatectomy (RP) patients face higher mortality from other diseases than prostate cancer. Focus on preventing and treating cardiovascular disease and other cancers post-surgery.

More Related Videos

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

Related Experiment Videos

Last Updated: May 27, 2026

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Published on: May 19, 2022

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

Area of Science:

Urology
Oncology
Public Health

Background:

Radical prostatectomy (RP) is a common treatment for localized prostate cancer.
Assessing long-term survival requires accounting for competing causes of death.

Purpose of the Study:

To evaluate cause-specific mortality after RP in a US population.
To adjust for competing risks in mortality analysis.

Main Methods:

Utilized the Surveillance, Epidemiology and End Results (SEER) database.
Identified 120,392 men undergoing RP for prostate cancer (1988-2003).
Analyzed cause-specific mortality data through 2006 using competing risks methods.

Main Results:

15-year prostate cancer mortality was 5.3%, while non-prostate cancer mortality was 30.6%.
Cardiovascular disease (11%), other cancers (9.1%), and other causes (10.5%) were leading non-cancer causes of death.
Older men (≥65 years) had higher non-prostate cancer mortality (40.8%).

Conclusions:

Mortality from cardiovascular disease, other cancers, and other causes exceeds prostate cancer death post-RP.
Emphasizes the need for comprehensive health management, including prevention and treatment of non-cancerous conditions in prostate cancer patients.